+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Hemostasis and Tissue Sealing Agents Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Topical Hemostats , Tissue Sealing Agents , Adhesives ), By Material (Collagen-based Agents, Gelatin-based Agents, Oxidized Regenerated Cellulose (ORC)-based Agents, Polysaccharide-based Agents, Synthetic Polymers), By Application (General Surgery, Minimally Invasive Surgery, Cardiovascular Surgery, Orthopedic Surgery, Trauma & Burn Management), By End-User (Hospitals & Surgical Centers, Ambulatory Surgical Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hemostasis and Tissue Sealing Agents Market size is forecast to increase from $10.49 Billion in 2026 to $21.52 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007577
Pages: 216 Pages

Hemostasis Analyzers Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Clinical Laboratory Analyzers , Point-of-Care (POC) Testing Analyzers, Reagents & Consumables, Integrated Software & Systems), By Technology (Optical Detection Technology , Mechanical Detection Technology, Electrochemical & Magnetic Detection, Microfluidics & Lab-on-a-Chip), By Test Type (Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Fibrinogen Testing, Activated Clotting Time (ACT) Testing, Platelet Function Tests), By End-User (Clinical Laboratories, Hospitals & Emergency Departments, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hemostasis Analyzers Market size is forecast to increase from $4.59 Billion in 2026 to $7.83 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007576
Pages: 227 Pages

Hemorrhoid Treatment Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Band Ligators, Infrared Coagulators, Proctoscopes & Anoscopes, Bipolar Probes, Doppler-Guided Ligators, Cryotherapy Devices, Laser Probes, Stapling Devices), By Technology Platform (Energy-Based Devices, Mechanical Devices, Hybrid), By Hemorrhoid Grade (Grade I, Grade II, Grade III, Grade IV), By End User (Hospitals, Clinics & Physician Offices, Ambulatory Surgery Centers, Home-Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Hemorrhoid Treatment Devices Market size is forecast to increase from $1.17 Billion in 2026 to $1.94 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007575
Pages: 220 Pages

Hemorrhagic Stroke Treatment Devices Market Size, Share and Growth Outlook, 2026: Analysis By Device (Embolization Coiling Systems, Intrasaccular Flow Disruption Devices, Flow Diversion Systems, Liquid Embolization Agents, Stent Retriever Systems, Aspiration-Based Thrombectomy Systems, Microcatheters, Guiding & Distal Access Catheters), By Indication (Intracranial Aneurysm, Arteriovenous Malformation , Chronic Subdural Hematoma ), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Neurosurgery Centers) Companies, and Country Forecast, 2021 to 2034

Global Hemorrhagic Stroke Treatment Devices Market size is forecast to increase from $1.69 Billion in 2026 to $3.08 Billion in 2034 at a CAGR of 7.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007574
Pages: 230 Pages

Hemophilia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Disease Indication (Hemophilia A, Hemophilia B, Hemophilia C), By Therapy Type (Recombinant Therapy, Plasma-Derived Therapy, Gene Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hemophilia Drugs Market size is forecast to increase from $16.32 Billion in 2026 to $27.62 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007573
Pages: 222 Pages

Hemophilia B Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Factor IX Replacement Therapy , Extended Half-Life , Gene Therapy , Non-Factor Therapies ), By Severity (Severe Hemophilia B, Moderate Hemophilia B, Mild Hemophilia B), By Route of Administration (Intravenous (IV), Subcutaneous (SC)), By End-User (Hospitals & Specialty Clinics, Hemophilia Treatment Centers (HTCs), Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Hemophilia B Market size is forecast to increase from $5.58 Billion in 2026 to $9.88 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007572
Pages: 220 Pages

Hemophilia A Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Factor VIII Replacement Therapy , Non-Factor Replacement Therapy , Extended Half-Life (EHL) Products, Gene Therapy Products, Desmopressin & Antifibrinolytic Agents), By Patient Type (With Inhibitors , Without Inhibitors ), By Treatment Regime (Prophylaxis Treatment, On-demand (Episodic) Treatment), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Hemophilia Treatment Centers (HTCs)) Companies, and Country Forecast, 2021 to 2034

Global Hemophilia A Drugs Market size is forecast to increase from $12.21 Billion in 2026 to $19.91 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007571
Pages: 230 Pages

Hemoglobinopathies Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Sickle Cell Disease , Thalassemia , Hemoglobin Variants ), By Treatment Type (Blood Transfusion , Iron Chelation Therapy, Pharmacological Therapy , Stem Cell Transplantation , Gene Therapy & Gene Editing ), By End-User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hemoglobinopathies Treatment Market size is forecast to increase from $13.59 Billion in 2026 to $34.87 Billion in 2034 at a CAGR of 12.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007570
Pages: 219 Pages

Hemoglobinopathies Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Sickle Cell Disease, Thalassemia , Hemoglobin Variants), By Test Type (Routine Red Blood Cell , Genetic Testing, High Performance Liquid Chromatography , Hemoglobin Electrophoresis , Hemoglobin Isoelectric Focusing , Hemoglobin Solubility Test), By Treatment Modality (Pharmacological Treatment, Biological Therapy , Transfusion Based Therapy, Hematopoietic Stem Cell Transplantation), By End User (Hospitals, Diagnostic Laboratories, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hemoglobinopathies Market size is forecast to increase from $12.73 Billion in 2026 to $33.6 Billion in 2034 at a CAGR of 12.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007569
Pages: 214 Pages

Hemoglobin Testing Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Automated Hematology Analyzers, Point-of-Care Devices, Reagents and Consumables), By Technology (Chromatography, Immunoassay, Enzymatic Assays, Electrophoresis), By Application (Anemia Screening, Diabetes Monitoring , Gestational Diabetes Management, Chronic Conditions Management), By End User (Hospitals & Clinics, Diagnostic Laboratories, Research Centers, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Hemoglobin Testing Market size is forecast to increase from $3.05 Billion in 2026 to $4.65 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007568
Pages: 214 Pages